# A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine

> **NCT00000628** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 27 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** L-697,661
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00000628
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 27 (—)
- **Last updated:** 2008-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000628, "A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*